The total return over the past 12 months is -19.63% vs. +16.94% for the S&P 500. So far it's up +54.05% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (19.63%) | (6.77%) | (52.57%) | N/A | N/A | N/A |
| Total Return CAGR | (19.63%) | (6.77%) | (52.57%) | N/A | N/A | N/A |
| Revenue CAGR | (62.78%) | +5.89% | +8.31% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Celularity Inc. (CELU)
| Year | Start price | End price | CELU Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $1.11 | $1.71 | +54.05% | +14.51% | +39.54% |
| 2025 | $2.08 | $1.11 | (46.63%) | +17.72% | (64.35%) |
| 2024 | $2.47 | $2.08 | (15.79%) | +24.89% | (40.68%) |
| 2023 | $12.90 | $2.47 | (80.85%) | +26.19% | (107.04%) |
| 2022 | $51.20 | $12.90 | (74.80%) | (18.17%) | (56.63%) |
| 2021 | $110.00 | $51.20 | (53.45%) | +28.74% | (82.19%) |
| 2020 | $99.50 | $110.00 | +10.55% | +18.37% | (7.82%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
